Background: Previous cross‐sectional studies have identified wide practice pattern variations in the use of peripheral vascular interventions (PVIs) for the treatment of claudication. However, there are limited data on longitudinal practice patterns. We aimed to describe the temporal trends and charges associated with PVI use for claudication over the past 12 years in the United States. Methods and Results: We conducted a retrospective analysis using 100% Medicare fee‐for‐service claims data to identify all patients who underwent a PVI for claudication between January 2011 and December 2022. We evaluated the trends in utilization and Medicare‐allowed charges of PVI according to anatomic level, procedure type, and intervention settings using generalized linear models. Multinomial logistic regressions were used to evaluate factors associated with different levels and types of PVI. We identified 599 197 PVIs performed for claudication. The proportional use of tibial PVI increased 1.0% per year, and atherectomy increased by 1.6% per year over the study period. The proportion of PVIs performed in ambulatory surgical centers/office‐based laboratories grew at 4% per year from 12.4% in 2011 to 55.7% in 2022. Total Medicare‐allowed charges increased by $11 980 035 USD/year. Multinomial logistic regression identified significant associations between race and ethnicity and treatment setting with use of both atherectomy and tibial PVI. Conclusions: The use of tibial PVI and atherectomy for the treatment of claudication has increased dramatically in in ambulatory surgical center/office‐based laboratory settings, non‐White patients, and resulting in a significant increase in health care charges. There is a critical need to improve the delivery of value‐based care for the treatment of claudication.
An estimated 100,306 people died from an overdose from May 2020 to April 2021. Emergency Medical Services (EMS) are often the first responder to opioid overdose, and EMS encounter records can provi...
1 July 2025 in Circulation: Cardiovascular Quality and Outcomes
BACKGROUND: The accuracy of contemporary administrative claims codes to discriminate between different phenotypes of peripheral artery disease is not well defined. We aimed to validate a predefined set of International Classification of Diseases, Tenth Revision , codes used to distinguish between claudication and chronic limb-threatening ischemia (CLTI) and to optimize their diagnostic accuracy using a supervised machine-learning approach. METHODS: We included all patients who underwent a peripheral vascular intervention for claudication or CLTI in the US Medicare-matched VQI-VISION (Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network) registry database between January 2016 and December 2019. Gold standard claudication and CLTI diagnoses were determined using VQI (Vascular Quality Initiative) registry data. These diagnoses were compared with a predetermined set of International Classification of Diseases, Tenth Revision , codes in the Medicare-matched data set. We used traditional logistic regression modeling and 6 machine-learning models to distinguish claudication from CLTI. We evaluated the sensitivity, specificity, total agreement, and area under the curve for all models, implementing grid search cross-validation to boost machine-learning model performance. RESULTS: Of 54 180 patients who underwent a peripheral vascular intervention (mean age, 71.9±10.0 years; 41.0% female; 74.2 non-Hispanic White), 20 769 (38.3%) had claudication and 33 411 (61.7%) had CLTI per gold standard registry definitions. The predefined set of International Classification of Diseases, Tenth Revision , codes had high sensitivity (80.9%), specificity (81.9%), and total agreement (81.3%) for distinguishing claudication versus CLTI. Traditional logistic regression improved sensitivity to 96.2%, but with a substantial drop in specificity (41.8%) and an area under the curve of 0.785. Of the machine-learning models, gradient boosting classifier performed the best (area under the curve, 0.892), improving sensitivity to 88.6% and total agreement to 84.2% with minimal drop in specificity (77.1%). CONCLUSIONS: International Classification of Diseases, Tenth Revision , codes can be used to discriminate between claudication and CLTI in claims data. Our defined set of claims codes can be used by investigators to accurately distinguish between these 2 peripheral artery disease phenotypes.
Background: Driving physician behavior change has been an elusive goal for quality improvement efforts aimed at reducing low-value care. We proposed the use of “nudge” interventions at the surgeon level in order to reduce post-surgical opioid overprescribing in accordance with consensus guidelines. Methods: We used 2017 Medicare data to identify outlier surgeons. A peer data benchmarking report that showed each surgeon the average number of opioid tablets they prescribed for an open inguinal hernia repair procedure from January 1, 2017 to December 31, 2017. We conducted a 1:1 randomized controlled trial providing outlier surgeons a report of their opioid prescribing patterns for a standard operation compared to the national average and prescribing guidelines. Results: There were 489 surgeons randomized to the intervention, of which 180 (36.8%) had data in the post-intervention period. Data was available for 87 surgeons in the intervention group and 93 surgeons in the control group. 97.7% of surgeons in the intervention group reduced their opioid prescribing pattern compared to 95.7% in the control group. Surgeons who received the data benchmarking report intervention prescribed 14.3% less opioids than surgeons in the control group (10.54 (SD 5.34) vs. 12.30 (SD 6.02), P = .04). The intervention was associated with a 1.83 lower mean number of opioid tablets prescribed per patient in the multivariable linear regression model after controlling for other factors (Intervention group vs. control group 95% CI [−3.61, −.04], P = .04). Discussion: The implementation of a peer data benchmarking intervention can drive physician behavior change towards high-value care.